Simplex Trading’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,172
| Closed | -$10K | – | 8780 |
|
|
2020
Q1 | $10K | Buy |
+2,172
| New | +$14.1K | ﹤0.01% | 6504 |
|
|
2019
Q4 | – | Sell |
-16,334
| Closed | -$162K | – | 8346 |
|
|
2019
Q3 | $170K | Buy |
16,334
+12,896
| +375% | +$169K | ﹤0.01% | 3739 |
|
|
2019
Q2 | $52K | Sell |
3,438
-6,729
| -66% | -$97.3K | ﹤0.01% | 4833 |
|
|
2019
Q1 | $130K | Sell |
10,167
-26,140
| -72% | -$296K | ﹤0.01% | 4070 |
|
|
2018
Q4 | $344K | Buy |
36,307
+27,037
| +292% | +$351K | ﹤0.01% | 2588 |
|
|
2018
Q3 | $153K | Buy |
9,270
+2,232
| +32% | +$35.8K | ﹤0.01% | 3953 |
|
|
2018
Q2 | $112K | Sell |
7,038
-3,956
| -36% | -$70.6K | ﹤0.01% | 4163 |
|
|
2018
Q1 | $168K | Buy |
10,994
+2,400
| +28% | +$37.4K | 0.01% | 1373 |
|
|
2017
Q4 | $134K | Sell |
8,594
-842
| -9% | -$11.3K | 0.01% | 1579 |
|
|
2017
Q3 | $104K | Buy |
9,436
+5,878
| +165% | +$55.3K | ﹤0.01% | 1676 |
|
|
2017
Q2 | $32K | Sell |
3,558
-3,597
| -50% | -$30K | ﹤0.01% | 2825 |
|
|
2017
Q1 | $61K | Buy |
+7,155
| New | +$65.2K | ﹤0.01% | 2191 |
|
|
2016
Q4 | – | Sell |
-671
| Closed | -$7K | – | 6856 |
|
|
2016
Q3 | $7K | Buy |
+671
| New | +$5.46K | ﹤0.01% | 4023 |
|
|
2016
Q2 | – | Sell |
-9,883
| Closed | -$46K | – | 6742 |
|
|
2016
Q1 | $46K | Buy |
+9,883
| New | +$48.3K | ﹤0.01% | 2021 |
|
Simplex Trading's STML Position: Q2 2020 in Review
Simplex Trading sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 2,172 shares — an estimated $10K sold.
Simplex Trading first reported a position in STML in Q1 2016 and held it in 14 quarters. The position peaked at $344K in Q4 2018. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- Simplex Trading reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- Simplex Trading sold 2,172 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $10K.
- Simplex Trading first reported a position in Stemline Therapeutics, Inc. in Q1 2016 and held it in 14 quarters.
- Simplex Trading's Stemline Therapeutics, Inc. position peaked at $344K in Q4 2018.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on Simplex Trading's 13F filing for Q2 2020, filed 13 Jul 2020.